OPK-88006

· OPKO Health, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPK-88006, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants [Phase 1, Phase 2]